Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prothymosin alpha pseudogene 5 is a processed pseudogene, part of the prothymosin alpha gene family in humans. Unlike the single functional gene in this family (PTMA), PTMAP5 does not encode a protein product and is not believed to be expressed as mRNA or protein in human tissues. It does not perform biological functions or serve as a drug target. The gene is present at chromosomal location 13q31.1 and has no known involvement in disease, biology, or therapeutic interactions. PTMAP5 is classified as a transcribed processed pseudogene, not as a functional protein-coding gene or target. Early studies found no evidence for expression of this and other prothymosin alpha pseudogenes in human tissues. There are no reported biological functions, disease associations, drug interactions, or biomarker utility for PTMAP5. The only functional member of this gene family is PTMA; all others, including PTMAP5, are non-functional processed pseudogenes. If you seek a therapeutic target or functional protein, PTMAP5 does not fit these criteria and the query should likely focus on the parental gene, PTMA, instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prothymosin alpha pseudogene 5 (PTMAP5).